Original Moxonidine and Generics: Where is the Edge of Difference?
The treatment with original moxonidine demonstrated advantages over generic drugs in terms of achieving the BP goal, reducing office BP and HR, and improving 24-h BPM parameters.
Authors
- Д. В. Сиротенко (ORCID: https://orcid.org/0000-0003-1787-628X)
- A. V. Skibitskiy (ORCID: https://orcid.org/0000-0001-6833-9033)
- А. В. Фендрикова (ORCID: https://orcid.org/0000-0002-4323-0813)
- О. В. Тимофеева (ORCID: https://orcid.org/0000-0003-1094-2301)
Institutions
- Kuban State Medical University (RU)
Publication Details
- Journal
- Kardiologiia
- Published
- 2024-08-31
- DOI
- https://doi.org/10.18087/cardio.2024.8.n2731
- Citations
- 2
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.80